144 related articles for article (PubMed ID: 15516962)
1. The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies.
Epstein RJ
Nat Rev Cancer; 2004 Nov; 4(11):901-9. PubMed ID: 15516962
[TBL] [Abstract][Full Text] [Related]
2. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.
Lévesque JP; Hendy J; Takamatsu Y; Simmons PJ; Bendall LJ
J Clin Invest; 2003 Jan; 111(2):187-96. PubMed ID: 12531874
[TBL] [Abstract][Full Text] [Related]
4. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
[TBL] [Abstract][Full Text] [Related]
8. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
Pelus LM; Fukuda S
Exp Hematol; 2006 Aug; 34(8):1010-20. PubMed ID: 16863907
[TBL] [Abstract][Full Text] [Related]
10. Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell transplantation.
Porecha NK; English K; Hangoc G; Broxmeyer HE; Christopherson KW
Stem Cells Dev; 2006 Jun; 15(3):325-33. PubMed ID: 16846371
[TBL] [Abstract][Full Text] [Related]
11. Functions of CXCL12 and CXCR4 in breast cancer.
Luker KE; Luker GD
Cancer Lett; 2006 Jul; 238(1):30-41. PubMed ID: 16046252
[TBL] [Abstract][Full Text] [Related]
12. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
[TBL] [Abstract][Full Text] [Related]
14. A proposed mechanism for the protective effect of dioxin against breast cancer.
Hsu EL; Yoon D; Choi HH; Wang F; Taylor RT; Chen N; Zhang R; Hankinson O
Toxicol Sci; 2007 Aug; 98(2):436-44. PubMed ID: 17517823
[TBL] [Abstract][Full Text] [Related]
15. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
Petit I; Szyper-Kravitz M; Nagler A; Lahav M; Peled A; Habler L; Ponomaryov T; Taichman RS; Arenzana-Seisdedos F; Fujii N; Sandbank J; Zipori D; Lapidot T
Nat Immunol; 2002 Jul; 3(7):687-94. PubMed ID: 12068293
[TBL] [Abstract][Full Text] [Related]
16. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells.
Guo Y; Hangoc G; Bian H; Pelus LM; Broxmeyer HE
Stem Cells; 2005 Oct; 23(9):1324-32. PubMed ID: 16210409
[TBL] [Abstract][Full Text] [Related]
17. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
[TBL] [Abstract][Full Text] [Related]
18. Chemokine stromal cell-derived factor 1alpha activates basophils by means of CXCR4.
Jinquan T; Jacobi HH; Jing C; Reimert CM; Quan S; Dissing S; Poulsen LK; Skov PS
J Allergy Clin Immunol; 2000 Aug; 106(2):313-20. PubMed ID: 10932076
[TBL] [Abstract][Full Text] [Related]
19. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?
Harvey JR; Mellor P; Eldaly H; Lennard TW; Kirby JA; Ali S
Clin Cancer Res; 2007 Mar; 13(5):1562-70. PubMed ID: 17332302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
